Receptor activator NF κB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis

…, H Weedon, M Capone, MJ Ahern… - Journal of …, 2003 - Wiley Online Library
Objectives and background: This study investigated the expression of key mediators that
regulate differentiation of osteoclasts, receptor activator of nuclear factor κB ligand (RANKL), …

Measuring grip strength in normal adults: reference ranges and a comparison of electronic and hydraulic instruments

N Massy-Westropp, W Rankin, M Ahern… - The Journal of hand …, 2004 - Elsevier
PURPOSE: To determine reference ranges for peak, average, and final adult grip strength
over 10 seconds by using an electronic dynamometer, and to compare results from hydraulic …

Suprascapular nerve block (using bupivacaine and methylprednisolone acetate) in chronic shoulder pain

EM Shanahan, M Ahern, M Smith… - Annals of the …, 2003 - ard.bmj.com
Background: Shoulder pain from inflammatory arthritis and/or degenerative disease is a
common cause of morbidity in the community. It is difficult to treat and there are limited data on …

Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFκB, RANK ligand and osteoprotegerin

TN Crotti, MD Smith, DM Findlay, H Zreiqat, MJ Ahern… - Biomaterials, 2004 - Elsevier
Aseptic bone loss adjacent to orthopedic joint implants is a common cause of joint implant
failure in humans. This study investigates the expression of key regulators of osteoclast …

The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations

…, PJ Maddison, N Goulding, I James, MJ Ahern… - Medicine, 1990 - journals.lww.com
In 1924 Felty (27) reported the association of arthritis with splenomegaly and leukopenia.
The eponym “the Felty syndrome” was established in the English literature by Hanrahan and …

Expression of Jak3, STAT1, STAT4, and STAT6 in inflammatory arthritis: unique Jak3 and STAT4 expression in dendritic cells in seropositive rheumatoid arthritis

JG Walker, MJ Ahern, M Coleman, H Weedon… - Annals of the …, 2006 - ard.bmj.com
Background: Modulation of Jak-STAT signalling may provide an effective therapeutic
strategy in inflammatory arthritis. Objective: To document Jak-STAT expression in a cohort of …

The effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebo‐controlled trials

…, M Crotty, EM Shanahan, M Batterham, M Ahern - …, 2003 - academic.oup.com
Objective. To undertake a systematic review of randomized placebo‐controlled trials to
assess and rank the efficacy of pharmacological interventions in preventing radiological …

[HTML][HTML] The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8)

…, MD Smith, H Weedon, MJ Ahern… - Arthritis Research & …, 2000 - Springer
Paired synovial tissue samples were obtained from both clinically uninvolved (CU) and clinically
involved (CI) knee joints of eight rheumatoid arthritis (RA) patients. In addition, biopsies …

South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome

…, JG Walker, MD Smith, MJ Ahern… - … journal of rheumatic …, 2012 - Wiley Online Library
Aim: To investigate the relationship between scleroderma‐specific autoantibodies and
clinical phenotype and survival in South Australian patients with scleroderma. Method: Two …

[PDF][PDF] Decreased nailfold capillary density in limited scleroderma with pulmonary hypertension

…, CP Bond, MD Smith, MJ Ahern… - Asian Pacific Journal …, 1998 - apjai-journal.org
Approximately 20% of patients with the limited form of sclero derma will develop pulmonary
hypertension which is generally a late stage fatal complication. Why pulmonary hypertension …